you are being redirected

You will be redirected to the website of our parent company, Schönherr Rechtsanwälte GmbH: www.schoenherr.eu

;

healthcare & life sciences

Schoenherr's experts provide straight-to-the-point legal advice in all legal matters in the healthcare & life sciences industry.

Our Healthcare & Life Sciences team provides fully integrated legal advice across one of the most highly regulated and rapidly evolving industries. We combine deep, industry-specific regulatory expertise with comprehensive transactional, financing, dispute resolution, IP and compliance capabilities. 

With offices across Central Eastern Europe, we advise clients on both complex domestic and multi-jurisdictional matters, seamlessly coordinating cross-border projects across the region.

  • pharmaceuticals
  • medical devices and in vitro diagnostics
  • medical biotechnology, including cell, tissue and gene therapies, orphan drugs, and advanced therapy medicinal products
  • digital health, including health data regulation (EHDS), AI, telemedicine, remote care and digital therapeutics
  • food and feed
  • tobacco products, tobacco substitutes (like nicotine pouches) and psychotropic substances (like CBD)
  • chemicals
  • healthcare delivery and services, including hospitals, outpatient care providers and nursing and care facilities
  • general consumer goods, including toys
  • cosmetics
  • seeds

We advise all key stakeholders active in these industries, including manufacturers, distributors and operators, hospitals, physicians, insurers and other healthcare and care institutions, as well as enterprises ranging from innovative start ups to established multinational corporations and strategic and financial investors.

Our core strengths lie in life sciences regulatory advice and transactional work, in particular M&A, VC/PE and spin-off transactions, capital markets transactions (including IPOs), and financing. As a full-service law firm, we support clients throughout the entire business and product life cycle – from early-stage innovation and investment to market expansion and mature international operations.

back contact us
team

our team

Meet our team of healthcare & life sciences experts across the CEE offices.

team
newsletter

stay informed

Subscribe to our Healthcare & Life Sciences Newsletter.

subscribe now

Our Healthcare & Life Sciences practice is structured around the needs of the industry. We bring together regulatory, transactional, corporate, IP and dispute resolution expertise to deliver practical, strategic and commercially driven advice in regulated environments.

Life Sciences & Healthcare Regulatory

We provide regulatory advice across the full spectrum of healthcare and life sciences products, including pharmaceuticals, medical devices, biotechnology, digital health, food and feed, seeds, chemicals, cosmetics and select consumer goods.

  • regulatory clearance, authorisation and approval proceedings at both EU and national level
  • product classification and demarcation, including complex borderline issues between medicinal products, medical devices, in vitro diagnostics, foods and cosmetics
  • legal market access requirements, including pricing, reimbursement and health technology assessment (HTA)
  • qualification and classification of software as medical devices (SaMD), as well as telemedicine, e-health, e-medication, AI-driven solutions and health data regulation, including European Health Data Space (EHDS)
  • product safety, vigilance, post-market surveillance and regulatory reporting obligations
  • labelling, packaging and advertising compliance, including health claims, CLP-Regulation and promotional activities
  • strategic support in product marketing and national and cross-border distribution models, including supply chain compliance
  • crisis management, including national and international product recalls, safety corrective actions and authority communications
  • representation before national and European authorities and courts, including administrative, civil and regulatory proceedings

Transactional and Corporate Services

We provide comprehensive transactional and corporate advice for clients across the healthcare and life sciences value chain – from innovative start-ups and emerging growth companies to established multinational corporations – including regulated product manufacturers, healthcare providers, insurers, management teams and strategic and financial investors, as well as issuers and underwriters in capital markets transactions.

  • national and cross-border M&A, including buy-side and sell-side mandates and exits
  • investments by strategic and financial investors, including venture capital, growth equity and private equity funds, across all stages
  • establishment, acquisition and restructuring of healthcare facilities, including outpatient clinics, hospitals, primary healthcare units, nursing and care facilities and fitness studios
  • corporate matters, including company formations, joint ventures and group reorganisations
  • founder and start-up matters, including establishment, corporate structuring, financing rounds and strategic transactions
  • management team matters, including equity participations, management buy-outs and incentive structures
  • spin-off transactions, including carve-out structuring and post-separation arrangements
  • buy-and-build strategies, including platform acquisitions and add-on transactions
  • capital markets transactions, including initial public offerings (IPOs), secondary offerings and equity and debt capital markets issuances
  • financing transactions, including acquisition finance, growth financing and structured finance arrangements
  • approvals in transactions, including merger control, FDI and industry-specific clearances

In addition, we provide full transactional support, from due diligence and deal structuring to closing and post-closing integration.

Healthcare Providers, Medical and Care Institutions

We provide advisory services for hospitals, outpatient clinics, physician centres, nursing and care facilities, and other healthcare providers, covering regulatory, corporate, transactional and contentious matters across the full spectrum of healthcare delivery.

  • the establishment, operation, restructuring and (cross-border) transfer of group practices, primary healthcare units, hospitals, outpatient clinics, nursing and care facilities
  • healthcare facility law, including structural and operational requirements, needs assessments, quality management obligations and licensing and accreditation procedures
  • strategic and financial investor acquisitions involving healthcare providers and hospitals
  • service and licensing agreements with statutory health insurance funds and private insurers, including reimbursement and billing matters
  • public procurement and tendering procedures in the healthcare sector
  • physician employment, cooperation and partnership models, including the structuring of group practices and medical centres
  • medical law and professional liability matters, including duty of care standards, informed consent and documentation requirements

In addition, we provide representation before national and European authorities and courts, including medical malpractice and professional liability claims.

Contracts, Research, Development and Commercial Agreements

We advice on the drafting, negotiation and implementation of sector-specific agreements across the healthcare and life sciences value chain, including complex cross-border contractual frameworks and long-term strategic partnerships.

  • clinical trial, research and development, as well as quality, supply and manufacturing agreements, including CMO and CDMO arrangements
  • licensing and technology transfer agreements, including in-licensing and out-licensing arrangements, for pharmaceutical, biotech, medical device and digital health products
  • commercial and distribution agreements in regulated environments, including exclusive and non-exclusive distribution structures
  • co-promotion, co-marketing and co-development agreements
  • cooperation agreements with healthcare professionals and healthcare organisations, including consulting, advisory board and speaker arrangements
  • service level and outsourcing agreements for healthcare and life sciences operations, including IT services, data management and logistics
  • the regulatory aspects of commercial agreements, including advertising restrictions, anti-kickback rules and transparency obligations

Additional Practice Areas

In addition to our core regulatory and transactional practice, our clients benefit from seamless access to Schoenherr's dedicated specialists across a broad range of complementary practice areas essential to the healthcare and life sciences industries. These experts collaborate closely with our Healthcare & Life Sciences team to deliver comprehensive and fully integrated legal advice.

  • intellectual property law, including the protection, enforcement and strategic management of patents, trademarks, designs and copyrights, as well as IP-related advice in transactions and licensing, including IP due diligence, freedom-to-operate analyses and portfolio management
  • protection of trade secrets, confidential information and proprietary know-how
  • data protection and patient confidentiality, including GDPR compliance, health data governance and cross-border data transfers
  • technology and digital health regulation, AI governance, algorithm transparency and liability frameworks
  • cybersecurity, data breach response and regulatory notification obligations
  • dispute resolution, including product liability, antitrust, unfair competition and regulatory enforcement proceedings
  • representation before national and European authorities and courts
  • banking & finance, capital markets and real estate matters
team

our team

Meet our team of healthcare & life sciences experts across the CEE offices.

team
newsletter

stay informed

Subscribe to our Healthcare & Life Sciences Newsletter.

subscribe now
newsletter

EU pathways to health innovation: the Biotech Act I and medical device reform

On 2 July 2025, the European Commission published its Strategy for European Life Sciences (see here), setting out the objective of positioning the EU as the world's most attractive place for life sciences by 2030. The strategy announces a series of flagship actions to foster a dynamic and competitive life sciences ecosystem.

more
newsletter

The EU Medicinal Products Directive in the Balkans: are candidate countries aligned with its key provisions?

The European Commission has recognised the regulatory disparities that exist between EU Member States and the candidate Balkan countries. To address these differences, it has identified the need to assess national legal frameworks and provide recommendations to Balkan countries for aligning them with EU standards.

more
press release

Austria/Belgium: Schoenherr advises FRI-Invest GmbH and its shareholders on Fluidda's acquisition by Banook

Schoenherr advised FRI-Invest GmbH and its shareholders on the transaction structure and Austrian law aspects of Fluidda's acquisition by Banook. Previously, Schoenherr had also advised FRI-Invest GmbH on its initial investment in Fluidda.

more
publication

to the point: Healthcare & Life Sciences Q4/2025

Welcome to the second edition of to the point: Healthcare & Life Sciences – a new format designed to keep you informed about legal and regulatory developments shaping the sector across Europe.

Subscribe here.

more
publication

The Legal 500 Country Comparative Guide 2025: Pharmaceutical Advertising in Bulgaria

more
press release

Romania: Schoenherr advises Calla Oradea shareholders on sale of majority stake in clinic to Integral Capital Group

Schoenherr advised the founders of Calla Oradea, an infertility diagnosis and treatment centre, on the sale of a majority stake in the clinic to Integral Capital Group. 

more

find all healthcare & life sciences news here

Subscribe to our newsletter

team

our team

Meet our team of healthcare & life sciences experts across the CEE offices.

team
newsletter

stay informed

Subscribe to our Healthcare & Life Sciences Newsletter.

subscribe now